documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

81 rows where docket_id = "FDA-1995-S-0036" and posted_year = 2009 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)

document_type 2

posted_year 1

  • 2009 · 81 ✖

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1995-S-0036-0109 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 38 - Baylor College of Medicine Public Disclosure on IND 100,681 Other RPT-Report 2009-12-31T05:00:00Z 2009 12 2009-12-31T05:00:00Z   2013-07-27T23:02:32Z   0 0 0900006480a6b5ec
FDA-1995-S-0036-0108 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 37 - Laerdal Medical Public Disclosure on IDE No. G020121 Other RPT-Report 2009-09-02T04:00:00Z 2009 9 2009-09-02T04:00:00Z   2013-07-27T22:52:13Z   0 0 0900006480a0c79e
FDA-1995-S-0036-0107 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 36 - Georgetown University Medical Center (IDE # GO50077-MR & Recanalization of Stroke Clots Using Embolectiomy (MR RESCUE) Other RPT-Report (outside of agency unless indicated) 2009-08-13T04:00:00Z 2009 8 2009-08-13T04:00:00Z   2013-07-27T22:50:15Z   0 0 09000064809fb0d8
FDA-1995-S-0036-0106 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 University of Washington School of Medicine re Normal Saline Infusin at 4 Degree Celsius, Public Disclosure Material Progress Report for IND 69,382 Report 35 Other Report 2009-08-03T04:00:00Z 2009 8 2009-08-03T04:00:00Z   2014-11-28T20:02:14Z   0 0 09000064809f46dd
FDA-1995-S-0036-0104 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 17 - Northfield Laboratories, Inc. - Public Disclosure Information Other RPT-Report (outside of agency unless indicated) 2009-06-11T04:00:00Z 2009 6 2009-06-11T04:00:00Z   2021-02-05T19:06:41Z   0 0 090000648055b0b9
FDA-1995-S-0036-0105 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 17 - "Lehigh Valley Hospital" - [Northfield Laboratories, Inc. - Public Disclosure Information] Supporting & Related Material RPT-Report (Supporting and Related Material) 2009-06-11T04:00:00Z 2009 6     2021-02-05T19:06:41Z   0 0 090000648055b0bc
FDA-1995-S-0036-0103 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Supplement Public Disclosure Material from Advanced Circulatory Systems, Inc., re IDE #G050062 Other SUP-Supplement 2009-06-10T04:00:00Z 2009 6 2009-06-10T04:00:00Z   2014-11-28T19:56:26Z   0 0 09000064809c4c90
FDA-1995-S-0036-0102 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Resuscitation Outcomes Consortium (ROC), INDs 12505 & 12506 Public Disclosure Material Report 34 - Report Other Report 2009-02-10T05:00:00Z 2009 2 2009-02-10T05:00:00Z   2021-02-05T19:05:15Z   0 0 0900006480847da9
FDA-1995-S-0036-0029 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Baxter INDA#6859 - Supplement 7 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:29Z   0 0 090000648055afe6
FDA-1995-S-0036-0038 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Baxter INDA#6859 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:35Z   0 0 090000648055afff
FDA-1995-S-0036-0042 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Icos Corporation BB IND-7371 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:40Z   0 0 090000648055b025
FDA-1995-S-0036-0099 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:14Z   0 0 090000648055b0da
FDA-1995-S-0036-0070 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc, BB IND 10719, Poly-SFH-P Injection Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:52Z   0 0 090000648055b200
FDA-1995-S-0036-0079 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 19 - William Beaumont Hospital - Public Disclosure Information Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:05:00Z   0 0 090000648055b2f2
FDA-1995-S-0036-0030 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Cardiologic Systems, Inc IDE G960214/S5 - SUP11 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:29Z   0 0 090000648055afeb
FDA-1995-S-0036-0032 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Cardiologic Systems, Inc IDE G960214/9 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:31Z   0 0 090000648055aff0
FDA-1995-S-0036-0035 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Cardiologic Systems, Inc IDE G960214 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:33Z   0 0 090000648055aff5
FDA-1995-S-0036-0037 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Baxter INDA#6859 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:34Z   0 0 090000648055affd
FDA-1995-S-0036-0084 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Memphis Paper - [Report 3 - ICOS Corp. (BB IND-7371) - Public Disclosure Information] Supporting & Related Material RPT-Report (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:04Z   0 0 090000648055b00f
FDA-1995-S-0036-0048 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 11 - Public Access Defibrillation (PAD) Trial - [IDE #G980067] - Public Disclosure Information Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:37Z   0 0 090000648055b084
FDA-1995-S-0036-0085 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Listing 1 - Memphis Survey Results, October 9, 2003 - [Report 12 - Northfield Laboratories, Inc. - Public Disclosure Information] Part 2 of 3 Supporting & Related Material RPT-Report (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:05Z   0 0 090000648055b087
FDA-1995-S-0036-0053 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 18 - Northfield Laboratories, Inc. - Public Disclosure Information Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:41Z   0 0 090000648055b0be
FDA-1995-S-0036-0090 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 University of Washington IDE#G980067 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:08Z   0 0 090000648055b0c1
FDA-1995-S-0036-0062 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:47Z   0 0 090000648055b1b8
FDA-1995-S-0036-0069 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:52Z   0 0 090000648055b1f1
FDA-1995-S-0036-0071 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc, BB IND 10719, Poly-SFH-P Injection Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:53Z   0 0 090000648055b204
FDA-1995-S-0036-0073 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:55Z   0 0 090000648055b23d
FDA-1995-S-0036-0074 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:55Z   0 0 090000648055b296
FDA-1995-S-0036-0056 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:43Z   0 0 090000648055b0c6
FDA-1995-S-0036-0092 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:09Z   0 0 090000648055b0ca
FDA-1995-S-0036-0057 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:44Z   0 0 090000648055b0cd
FDA-1995-S-0036-0058 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:44Z   0 0 090000648055b0cf
FDA-1995-S-0036-0098 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:13Z   0 0 090000648055b0d9
FDA-1995-S-0036-0064 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:48Z   0 0 090000648055b1c0
FDA-1995-S-0036-0075 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:56Z   0 0 090000648055b29a
FDA-1995-S-0036-0077 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories, Inc. (BB IND #10719) - Supplement(49) Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:59Z   0 0 090000648055b2c5
FDA-1995-S-0036-0101 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 University of Washington - Comment re Public Disclosure Material IND 52,523 for Magnesium Sulfate and Diazepam Injection After Cardiac Arrest Other Disclosure of Date and Information 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:05:15Z   0 0 090000648055affb
FDA-1995-S-0036-0045 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 6 - Baxter (INDA#6859) - Public Disclosure Information Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:42Z   0 0 090000648055b042
FDA-1995-S-0036-0089 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 18 - "Metro Health Center" - [Northfield Laboratories, Inc. - Public Disclosure Information] Supporting & Related Material RPT-Report (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:07Z   0 0 090000648055b0bf
FDA-1995-S-0036-0081 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 32 - Northfield Laboratories, Inc. [BB IND 10719] - Final Public Disclosure Information Other RPT-Report 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:05:02Z   0 0 09000064807b3f1a
FDA-1995-S-0036-0083 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 33 - Immediate Trial [Bellingham, Washington and El Paso, Texas Public Disclosure Material (IND 70,376) - Report Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:05:03Z   0 0 0900006480830852
FDA-1995-S-0036-0093 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:10Z   0 0 090000648055b0d0
FDA-1995-S-0036-0096 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:12Z   0 0 090000648055b0d4
FDA-1995-S-0036-0097 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:12Z   0 0 090000648055b0d5
FDA-1995-S-0036-0061 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:46Z   0 0 090000648055b139
FDA-1995-S-0036-0066 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:50Z   0 0 090000648055b1c3
FDA-1995-S-0036-0076 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories BB IND #10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:58Z   0 0 090000648055b29f
FDA-1995-S-0036-0039 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 ICOS Corporation, Community Consultation and Public Disclosure information for Waiver of Informed Consent, BB IND-7371, Public Disclosure Information, Report 3 - Report Other Report 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:36Z   0 0 090000648055b012
FDA-1995-S-0036-0044 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Icos Corporation BB IND-7371 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:41Z   0 0 090000648055b02a
FDA-1995-S-0036-0046 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 CPR, LLC IDE# 980125 Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:35Z   0 0 090000648055b044
FDA-1995-S-0036-0047 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Concentric Medical, Inc. Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:36Z   0 0 090000648055b047
FDA-1995-S-0036-0052 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 16 - Harborview Medical Center - Public Disclosure Information Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:40Z   0 0 090000648055b0b4
FDA-1995-S-0036-0054 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 University of Washington IDE#G980067 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:41Z   0 0 090000648055b0c3
FDA-1995-S-0036-0034 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Baxter INDA#6859 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:32Z   0 0 090000648055aff3
FDA-1995-S-0036-0031 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Cardiologic Systems, Inc IDE G960214/S6 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:30Z   0 0 090000648055afed
FDA-1995-S-0036-0033 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Cardiologic Systems, Inc IDE G960214/10 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:31Z   0 0 090000648055aff1
FDA-1995-S-0036-0036 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Baxter INDA#6859 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:34Z   0 0 090000648055aff9
FDA-1995-S-0036-0040 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 4 - Cardiologic Systems, Inc IDE G960214 - Public Disclosure Information Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:38Z   0 0 090000648055b013
FDA-1995-S-0036-0049 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 12 - Northfield Laboratories, Inc. - Public Disclosure Information Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:38Z   0 0 090000648055b089
FDA-1995-S-0036-0051 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 15 - Northfield Laboratories, Inc. [BB IND # 10719] - Public Disclosure Information Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:39Z   0 0 090000648055b0af
FDA-1995-S-0036-0088 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Community Consultation - [Report 15 - Northfield Laboratories, Inc. [BB IND # 10719] - Public Disclosure Information] Supporting & Related Material RPT-Report (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:06Z   0 0 090000648055b0b3
FDA-1995-S-0036-0091 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:08Z   0 0 090000648055b0c8
FDA-1995-S-0036-0094 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:10Z   0 0 090000648055b0d1
FDA-1995-S-0036-0095 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:11Z   0 0 090000648055b0d2
FDA-1995-S-0036-0065 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:49Z   0 0 090000648055b1c1
FDA-1995-S-0036-0072 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:54Z   0 0 090000648055b232
FDA-1995-S-0036-0080 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 20 - University of Texas Health Science Center at San Antonio Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:05:01Z   0 0 090000648055b2ff
FDA-1995-S-0036-0100 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 ROC Site and Status - [Report 23 - ROC [INDs 12505 & 12506] - Public Dislcosure Information] Supporting & Related Material RPT-Report (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:14Z   0 0 090000648055b44f
FDA-1995-S-0036-0055 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:42Z   0 0 090000648055b0c5
FDA-1995-S-0036-0059 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:45Z   0 0 090000648055b0d6
FDA-1995-S-0036-0060 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:46Z   0 0 090000648055b0d8
FDA-1995-S-0036-0063 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:48Z   0 0 090000648055b1b9
FDA-1995-S-0036-0067 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:50Z   0 0 090000648055b1e7
FDA-1995-S-0036-0068 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Northfield Laboratories Inc BB IND 10719 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:51Z   0 0 090000648055b1ed
FDA-1995-S-0036-0078 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Executive Summary - [Northfield Laboratories, Inc. (BB IND #10719) - Supplement(49)] Supporting & Related Material SUP-Supplement (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:00Z   0 0 090000648055b2c8
FDA-1995-S-0036-0082 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 2 - Cardiologic Systems, Inc. - [IDE G960214/12] - Public Disclosure Information Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:05:03Z   0 0 090000648055afea
FDA-1995-S-0036-0041 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Baxter INDA#6859 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:39Z   0 0 090000648055b020
FDA-1995-S-0036-0043 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Icos Corporation BB IND-7371 Other SUP-Supplement 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:01:41Z   0 0 090000648055b028
FDA-1995-S-0036-0086 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Listing 1 - Memphis Survey Results, October 9, 2003 - [Report 12 - Northfield Laboratories, Inc. - Public Disclosure Information] Part 1 of 2 Supporting & Related Material RPT-Report (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:05Z   0 0 090000648055b088
FDA-1995-S-0036-0050 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Report 14 - Northfield Laboratories, Inc. [BB IND # 10719] - Public Disclosure Information Other RPT-Report (outside of agency unless indicated) 2009-01-29T05:00:00Z 2009 1 2009-01-29T05:00:00Z   2021-02-05T19:04:39Z   0 0 090000648055b0ae
FDA-1995-S-0036-0087 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Community Consultation - [Report 15 - Northfield Laboratories, Inc. [BB IND # 10719] - Public Disclosure Information] Supporting & Related Material RPT-Report (Supporting and Related Material) 2009-01-29T05:00:00Z 2009 1     2021-02-05T19:05:06Z   0 0 090000648055b0b1

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);